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Efficacy of endoscopic triage during the Covid-19 
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Maurizio Vecchia,b, Roberto Bertèa,b, Annarita Baldassarria and Roberto Penaginia,b 
Introduction
A SARS-CoV-2 outbreak has spread worldwide, Italy 
being a high-incidence country following a lockdown 
strategy to reduce contagions [1]. As a consequence of 
the new circumstances, the need to contain the infection 
spread and the need to dedicate personnel and resources 
to the management of Covid-19 patients, almost all endo-
scopic units underwent in-depth reorganization involving 
logistics, scheduling and selection of patients [2–4]. New 
spaces for infected patients and waiting rooms maintain-
ing appropriate human-to-human distancing have been 
prepared. Endoscopists and nurses have learnt how to 
use the personal protective equipment with a high-barrier 
effect and how to move around in the endoscopic rooms 
reducing the possibility of viral spread [5]. A novel triage 
was developed to identify and then perform only strictly 
necessary endoscopies. No data have been available about 
the efficacy of the novel ‘endoscopic triage’ adopted to 
limit the access to the endoscopic procedures.
We analyzed the efficacy of this newly adopted endo-
scopic triage compared to that in place during the non-
Covid-19 era.
Methods
From 9 to 27 March 2020, in the Endoscopy Unit of the 
Fondazione IRCCS Ca’ Granda, a tertiary referral Center 
in Milano, a new selection of patients undergoing endo-
scopic procedures has been started, guided by the need 
to reduce the number of investigations and consequently 
the viral spread and contagions [2]. In the case of esoph-
agogastroduodenoscopy (EGDS) and colonoscopy (CLS), 
procedures performed for oncological reasons, bleedings 
and other unpostponable indications have been main-
tained; in particular, subdivision of indications is present 
in Fig. 1. In the case of device-assisted enteroscopy [DAE, 
double balloon enteroscopy (DBE)], capsule endoscopy, 
endoscopic retrograde cholangiopancreatography (ERCP) 
and endoscopic ultrasonography (EUS), a case-by-case 
judgment has been adopted.
Clinical and demographic data of the patients have 
been recorded. Indications, type of endoscopy, endo-
scopic findings (subtyped in major and minor findings, 
Supplementary file 1, Supplemental digital content 1, 
http://links.lww.com/EJGH/A597), finding rates (major 
and minor findings) and diagnostic yields (major findings), 
as previously defined in the literature, have been analyzed 
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and compared to the endoscopic procedures performed in 
the corresponding 2019 timeframe [6,7].
All patients were called at least 21 days after the endos-
copy to evaluate the possibility of a Covid-19  onset; in 
particular, flu-like symptoms in the patients or cohabitants 
and/or positive PCR test have been evaluated [8].
Statistically, intergroup comparisons were performed 
by the Chi-square test or Fisher’s exact test, as appropri-
ate for discrete variables, and by the Student’s t-test or 
the Mann–Whitney test, as appropriate for continuous 
variables. P value <0.05 was considered statistically sig-
nificant. Analysis was performed by Graphpad software 
(GraphPad Software Inc, California, USA).
Results
Accordingly to the novel triage, the number of endoscopic 
procedures performed during Covid-19 outbreak drastically 
dropped from 530 to 91 (−84%). On March 2020, patients 
underwent endoscopy for bleeding in 32 (39%) cases, onco-
logic reason in 30 (37%), inflammatory bowel disease (IBD) 
in 3 (4%) and other indications in 16 (20%) (Table 1).
Globally, the finding rates and diagnostic yields were 
83% (74–89) vs 71% (66–73) (P 0.015) and 56% (46–
65) vs 43% (38–47) (P 0.03) on March 2020 and March 
2019, respectively. Age and sex were not associated with 
diagnostic yields neither on 2020 nor 2019. In Table 2 the 
diagnostic yields of the routinely endoscopic procedures 
are reported in detail.
Fig. 1. Flowchart of the study reporting the ‘crisis criteria’ and their pro and cons.
Table 1. Procedures performed in March 2020 compared to those in March 2019
March 2020 March 2019 P value
Patients    
 Age (years) 59 ± 13 63 ± 16 0.03
 Females (%) 43 (47.2%) 261 (49.4%) 0.64
Type of endoscopy    
 All, n 91 530 NA
 EGDS, n (%) 39 (31.8%) 255 (46%) 0.01
 Esophageal dilatation, n (%) 4 (4.4%) 2 (0.4%) 0.005
 Variceal band ligation, n (%) 4 (4.4%) 4 (0.8%) 0.005
 PEG positioning, n (%) 1 (1.0%) 4 (0.8%) 0.54
 Bioenteric intragastric balloon, n (%) 1 (1.0%) 1 (0.2%) 0.27
Colonoscopy 42 (46.0%) 222 (41.9%) 0.56
with polypectomy, n (%) 19 (20.9%) 52 (9.8%) 0.004
ERCP, n (%) 1 (1.0%) 21 (3.9%) 0.34
EUS, n (%) 0 (0.0%) 11 (2.1%) 0.38
DAE, n (%) 5 (5.5%) 8 (1.5%) 0.02
Anterograde, n 3 7 0.51a
Retrograde, n 2 1  
Capsule endoscopy, n (%) 4 (4.4%) 13 (2.4%) 0.29
DAE, device-assisted enteroscopy; EGDS, esophagogastroduodenoscopy; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic 
ultrasonography.
aAnterograde vs retrograde.
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Findings of the endoscopic procedures on March 2019 
and March 2020 demonstrated the relevant reduction of 
negative EGDS and CLS, from 30 to 10% and from 30 to 
16%. Findings are fully detailed in Table 3.
In terms of operative EGDS and CLS, in 2019, they 
represented the 22% of the endoscopies, in 2020 the 34% 
(P = 0.02).
On March 2020, an ERCP has been performed for 
choledocolithiasis and no EUS. Five DBEs have been per-
formed with a final diagnosis of active jejunal IBD, a case 
of multiple angiodysplasia, a case of segmental mucosal 
atrophy and two cases with normal findings. Among the 
four capsule endoscopies performed on 2020, one evi-
denced multiple jejunal angiodysplasia, one multiple jeju-
nal bleeding ulcers and two normal.
All the patients were recalled, neither cases of onset 
of Covid-19 like symptoms nor cases of positive naso-
pharyngeal swabs PCR have been evidenced. Also the 
cohabitants of patients referred any symptoms compatible 
with Covid-19.
Discussion
The present study is the first evaluating endoscopic perfor-
mance while adopting a new patients’ triage compatible 
with the actual pandemic scenario. Following the novel 
criteria, the number of procedures has drastically dropped 
(−84%) with a significant increase of finding rates and 
diagnostic yields; similarly, the percentage of operative 
endoscopies has been significantly higher. No Covid-19 
onset or infection has been noted after endoscopic proce-
dures in respect of the incubation period (at least 21 days) 
[8].
For the first time, endoscopy units faced the necessity 
to apply ‘war-time triage’ to schedule the patients’ access 
[2,3]. Reducing scheduled routine activities is one of the 
first steps to ease the pressure of a rapidly spreading infec-
tious agent, such as SARS-CoV-2, in a hospital healthcare 
provision. Priority should be given to those interventions 
that can substantially improve patients’ survival and post-
pone those which are not urgent nor strictly necessary 
[9]. Furthermore, triage is pivotal to preserve the health 
of healthcare professionals, as they are valuable limited 
resources during an epidemic outbreak [9].
On assessing patients undergoing endoscopy, we 
have identified bleedings, oncological patients and sev-
eral peculiar cases (Fig. 1) as unpostponable indications. 
We have chosen these categories on consideration that 
Table 2. Finding rates and diagnostic yields of esophagogastroduo-
denoscopy and colonoscopy in 2020 and 2019
Type of endoscopy March 2020 March 2019 P value
EGDS (%)    
 Finding rate (%) 90 (76–96) 70 (64–75) 0.0001
 Diagnostic yield (%) 45 (64–89) 79 (39–51) 0.0001
Colonoscopy (%)    
 Finding rate (%) 83 (69–92) 69 (63–75) 0.09
 Diagnostic yield (%) 33 (20–48) 30 (25–37) 0.71
EGDS, esophagogastroduodenoscopy.
Table 3. Endoscopic findings in March 2020 and March 2019
March 2020, N = 91 March 2019, N = 530
P value, compared to all 
procedures
P value, compared to the  
corresponding procedure
EGDS, n (%) 39 (42%) 255 (48%) 0.36 NA
Normal, n (%) 4 (4%) 76 (14%) 0.01 0.006
Major finding     
 Erosive esophagitis, n (%) 7 (8%) 21 (4%) 0.08 0.19
 Eosinophilic esophagitis, n (%) 0 (0%) 4 (0.7%) 1.0 1.0
 Erosive gastritis, n (%) 0 (0%) 12 (2%) 1.0 0.37
 Esophageal varices, n (%) 4 (4%) 35 (7%) 0.28 0.26
 Portal hypertensive gastropathy, n (%) 2 (2%) 5 (1%) 0.27 0.23
 Esophageal stenosis, n (%) 9 (10%) 2 (0.3) 0.0001 0.0001
 Esophageal cancer, n (%) 1 (1%) 0 (0%) 1.0 1.0
 Gastric peptic ulcer, n (%) 1 (1%) 9 (2%) 1.0 1.0
 Gastric polyps, n (%) 0 (0%) 7 (1%) 1.0 1.0
 Gastric cancer, n (%) 1 (1%) 1 (0.2%) 0.27 0.24
 Barrett’s esophagus, n (%) 0 (0%) 3 (0.5%) 1.0 1.0
 Erosive duodenitis, n (%) 0 (0%) 1 (0.2%) 1.0 1.0
 Duodenal peptic ulcer, n (%) 1 (1%) 5 (1%) 1.0 0.57
 Duodenal stenosis, n (%) 0 (0%) 1 (0.2%) 1.0 1.0
 Angiodysplasia, n (%) 4 (4%) 1 (0.2%) 0.02 0.012
 Atrophy, n (%) 1(1%) 4 (0.7%) 0.02 0.012
Minor finding, n (%) 4 (4%) 63 (12%) 0.04 0.06
Colonoscopy, n (%) 42 (46%) 222 (42%) 0.49 NA
Normal, n (%) 7 (8%) 68 (13%) 0.22 0.09
Major finding     
 Adenocarcinoma, n (%) 1 (1%) 7 (1%) 1.0 1.0
 Advanced lesion, n (%) 3 (3%) 9 (2%) 0.39 0.41
 ≥3 adenomas, n (%) 1 (1%) 3 (0.6%) 0.47 0.50
 Active IBD, n (%) 6 (7%) 27 (5%) 0.61 0.79
 Complicated diverticular disease, n (%) 0 (0%) 4 (0.8%) 1.0 1.0
 Ischemic colitis, n (%) 1 (1%) 2 (0.4%) 0.37 0.46
 Angiodysplasia, n (%) 2 (2%) 2 (0.4%) 0.10 0.12
 Hemorrhoid, n (%) 0 (0%) 7 (1%) 0.60 0.60
 Postpolipectomy bleeding, n (%) 0 (0%) 1 (0.2%) 1.0 1.0
 Stenosis, n (%) 0 (0%) 2(0.4%) 1.0 1.0
Minor finding, n (%) 21 (23%) 86 (16%) 0.13 0.17
 Unsuccessful, n (%) 0 (0%) 4 (0.8%) 1.0 1.0
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the endoscopic procedure has a potential impact on the 
patient’s prognosis in the short term. Particular attention 
should be paid to more advanced endoscopic techniques 
(DAE, ERCP and EUS). In secondary and tertiary centers, 
such procedures should be reserved and guaranteed. In our 
study, operative and diagnostic enteroscopy procedures 
(DBE and capsule endoscopy) have been reduced (−40 and 
−70%) but not suspended because of the bleeding risk in 
patients undergoing enteroscopy. EUS was not performed 
and ERCP was substantially reduced (−95%) with a sin-
gle patient with acute cholangitis and lithiasis undergoing 
ERCP. Such a situation most probably resulted from the 
rescheduling of palliative procedures and the reduction of 
the workload in surgical departments.
In spite of the realistic limits of this study, as the low 
number of patients, short follow-up, validation of the used 
tools and ethical concerns [10], the present report demon-
strates that the adopted triage increases finding rates and 
diagnostic yields; moreover, no infection has been trans-
mitted through endoscopy.
Despite the significant increase of finding rates and 
diagnostic yields shown in the March 2020 series, com-
pared to the March 2019 one, the other side of the coin is 
represented by the number of major findings unavoidably 
missed in March 2020 (see Table 3), due to the numerical 
reduction of patients undergoing endoscopic investiga-
tions. It should be kept in mind that a number of endo-
scopic procedures with a low pretest probability and an 
apparently inappropriate indication could still present a 
clinically relevant finding, which modifies the patient’s 
outcome and prognosis. Sometimes, these incidental 
endoscopic diagnoses contribute to increase the diagnos-
tic yields of the endoscopic investigations routinely per-
formed [11]. The impact of these ‘incidental lesions’ found 
during ‘not-fully appropriate’ endoscopies, is difficult to 
evaluate in our particular clinical setting in March 2020, 
influenced by the novel endoscopic triage with the need of 
limited access to the endoscopic unit. Moreover, to avoid 
missed diagnoses of severe diseases, the use of the current 
guidelines must be tailored to the specific clinical setting 
[12], also during the so-called phase 2, when a period of 
co-habitation with the SARS-CoV-2 should be prepared 
and the postponed procedures rescheduled. Beyond the 
Covid-19 outbreak scenario, the present study underlines 
the difficulty to apply a strict triage activity to reduce 
inappropriate investigations (and as a consequence the 
risk of SARS-CoV-2 infection). It is well known that also 
in the ‘pre-Covid-19 era’ activity was graved by a high 
number of inappropriate endoscopies, ranging from 30 to 
50% and especially in the case of upper endoscopy [7]. 
Furthermore, inappropriateness has been associated with 
a decrease of diagnostic efficacy and diagnostic yields [13]. 
Therefore, a strict adherence to appropriate indications is 
essential toward the rational use of available resources, 
and furthermore, a correct number of endoscopic proce-
dures is relevant to preserve personnel [9]; in fact, there 
is no certainty that there will no pandemic relapse with 
the need for operationally fit medical personnel. Figure 1 
reports a flowchart of the study with potential side effects 
of the crisis triage.
In conclusion, it is pivotal in this phase to carefully 
reprogram the endoscopic examinations by evaluating 
all the indications case by case. It is also clear that some 
shortcomings are to show up in postponed investigations; 
thus, the careful follow-up of canceled endoscopies should 
be carried out, preferably by means of telemedicine [14], 
toward the reprogramming of the next months’ activity.
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